Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CubeSmart (CUBE) vs Stryker Corporation (SYK) Price & Performance

Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

CubeSmart vs Stryker Corporation — how do they compare? CubeSmart trades at $37.56 (market cap $8.38B), while Stryker Corporation trades at $276.39 (market cap $105.64B). The key difference: Stryker Corporation is far larger — about 12.6× CubeSmart's market cap, and CubeSmart pays the higher dividend (5.69%). Which is the better fit depends on your goals — on Pluang, investors hold CubeSmart for 89 Days and Stryker Corporation for 20 Days on average.

CUBESYK
Market Cap
$8.38B$105.64B
Volume
2,231,3071,918,844
Sector
Real EstateHealth
52-Week High
$42.50$388.35
52-Week Low
$35.36$269.75
Typical Hold Time
89 Days20 Days
Enterprise Value
$11.91B$117.10B
Dividend Yield
5.69%1.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CubeSmart

CubeSmart (CUBE) trades at $37.51, down 0.66% on the day, with a bearish technical signal but improving operational trends. The REIT reported Q2 2026 earnings beats and raised full-year guidance, though funds from operations slightly missed estimates. Valuation ratios like P/E of 25.33 and P/S of 7.48 are elevated, while profitability remains solid with a 29.41% net income margin. Recent news highlights institutional buying and debates on REIT valuations amid AI sector shifts.

Outlook is mixed: analyst consensus targets $44.00 with a 'Buy' lean, but technicals and macroeconomic headwinds pose risks. The stock offers a 5.4% dividend yield, yet same-store NOI declines and high debt levels warrant caution. Upside depends on sustained occupancy gains and moderating supply pressures in the self-storage sector.

Stryker Corporation

Stryker (SYK) trades at $275.4, down 1.11% amid a bearish technical signal and negative news flow. The company maintains strong profitability with a 14.43% net margin and a 71% analyst buy rating, but faces headwinds from a manufacturing issue disclosure that triggered an 8.8% stock drop on September 8, 2026. Q3 2026 earnings are due October 29, 2026, following a mixed earnings history with a recent miss in Q1 2026.

The stock presents a divergence between solid fundamentals and near-term sentiment risks. The consensus price target of $368.11 implies significant upside, but ongoing legal investigations and operational challenges pose risks to investor confidence. Earnings growth and resolution of manufacturing issues are critical for sustained recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CUBE
97% Buy3% Sell
Avg holding period · 89 Days
SYK
1% Buy99% Sell
Avg holding period · 20 Days

Top news

Latest headlines on both assets

About CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Read more on CUBE →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →